ri:val delivers focused tools

ri:val as the leading solution for valuation in life sciences has changed the way in which business development and investors approach the value question. In the past, valuation has been seen as a black box or an art based on hundreds of diverging approaches. Today, ri:val sets the standard in how valuation is applied to life sciences. There is no more need for elaborate spreadsheets and complicated models or for accepting statements such as, “valuation does not give any reliable results.” ri:val lets you lay the groundwork for rational negotiations in business development and in investing. Investors, portfolio managers, and business developers alike can now base their decisions on reproducible and transparent valuations.

 

rival provides solutions to these markets:

Business Development /Licensing

Fundraising / IPO

Portfolio Management

Mergers & Acquisitions

Investing